Skip to main content
. 2018 Apr 30;33(1):867–878. doi: 10.1080/14756366.2018.1462802

Table 4.

Selectivity for compounds 7b, 10e, and Sunitinib towards tumor and non-tumorigenic cell lines.

  IC50 (µM) ± SD
 
Compound No. Intestine IEC-6 Breast MCF-10A Fibroblast Swiss-3t3 NSCLC
A-549
Mean
tumor selectivity
7b 8.70 ± 4.32 3.42 ± 0.45 6.85 ± 0.76 3.84 ± 0.67 1.6
10e 8.98 ± 1.25 5.37 ± 0.61 8.51 ± 1.01 4.13 ± 0.61 1.8
Sunitinib 4.56 ± 0.54 4.43 ± 0.23 4.07 ± 0.75 3.06 ± 0.9 1.4